Article citationsMore>>

Wang, S., Ma, P., Zhang, S., Song, S., Wang, Z., Ma, Y., et al. (2020) Fasting Blood Glucose at Admission Is an Independent Predictor for 28-Day Mortality in Patients with COVID-19 without Previous Diagnosis of Diabetes: A Multi-Centre Retrospective Study. Diabetologia, 63, 2102-2111.
https://doi.org/10.1007/s00125-020-05209-1

has been cited by the following article:

• TITLE: Early Hyperglycemia in Diabetics as a Predictor of Disease Severity in COVID-19

  AUTHORS: Niaz Ahmed Shaikh, Arshee Khan, Asnin Shah, Rubina Inamdar, Rania Abusalma, Rafeh Jamal

  KEYWORDS: Admission Hyperglycemia, COVID-19, Diabetes, Disease Severity

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.12 No.12, December 14, 2021

  ABSTRACT: Background: Hyperglycemia is an important predictor of prolonged hospitalization and mortality. The objective of this study was to analyze the role of early hyperglycemia in predicting the severity of COVID-19 illness and mortality. Method: Retrospective study on 259 patients with COVID-19 with measurement of average glucose during 24 hours of admission. Association of Early Hyperglycemia categorized as 180 mg/dl; was studied with mortality, requirement of ICU stay and prognostic markers. Results: Early hyperglycemia (>180 mg/dl) revealed a higher median value for CRP (109 mg/l [IQR; 48 - 199]) in comparison to 180 mg/dl group; 24 (15.9%) vs 14 patients (13%) [p = 0.51] in the 180 mg/dl was 8 (5.3%) while Conclusion: Hyperglycemia in the first 24 hours may anticipate an increased risk of ICU stay and a higher mortality rate. It may be a possible predictor of disease severity.